Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Oct;102(4):936-938.
doi: 10.1016/j.kint.2022.07.008. Epub 2022 Jul 20.

COVID-19 morbidity decreases with tixagevimab-cilgavimab preexposure prophylaxis in kidney transplant recipient nonresponders or low-vaccine responders

Hannah Kaminski  1 , Mickael Gigan  2 , Agathe Vermorel  1 , Manon Charrier  1 , Laura Guirle  2 , Frederic Jambon  1 , Arthur Lacapère  1 , Coline Ménard  1 , Karine Moreau  1 , Martine Neau-Cransac  1 , Marine Novion  1 , Frederique Pribat  2 , Benjamin Taton  1 , Sébastien Borde  3 , Laure Burguet  4 , Charlie Martinez  5 , Magali Jasiek  6 , Pauline D'Halluin  7 , Marie-Edith Lafon  8 , Pierre Merville  1 , Lionel Couzi  9
Affiliations
Comment

COVID-19 morbidity decreases with tixagevimab-cilgavimab preexposure prophylaxis in kidney transplant recipient nonresponders or low-vaccine responders

Hannah Kaminski et al. Kidney Int. 2022 Oct.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Survival-free from Omicron infection. (a) Symptomatic coronavirus disease 2019 (COVID-19)–free survival. (b) COVID-19–related hospitalization-free survival. (c) COVID-19–related intensive care unit hospitalization-free survival. (d) Survival-free from death due to COVID-19. Log-rank test was used to compare the 2 groups and was considered as significant when P < 0.05.
See this image and copyright information in PMC

Comment on

References

    1. Caillard M.P.S., Anglicheau M.P.D., Matignon M.D.M., et al. An initial report from the French SOT COVID Registry suggests high mortality due to Covid-19 in recipients of kidney transplants. Kidney Int. 2020;98:1549–1558. - PMC - PubMed
    1. Bertrand D., Hamzaoui M., Lemée V., et al. Antibody and T cell response to SARS-CoV-2 messenger RNA BNT162b2 vaccine in kidney transplant recipients and hemodialysis patients. J Am Soc Nephrol. 2021;32:2147–2152. - PMC - PubMed
    1. Levin M.J., Ustianowski A., Wit S.D., et al. Intramuscular AZD7442 (tixagevimab–cilgavimab) for prevention of Covid-19. N Engl J Med. 2022;386:2188–2200. - PMC - PubMed
    1. Iketani S., Liu L., Guo Y., et al. Antibody evasion properties of SARS-CoV-2 Omicron sublineages. Nature. 2022;604:553–556. - PMC - PubMed
    1. Takashita E., Kinoshita N., Yamayoshi S., et al. Efficacy of antiviral agents against the SARS-CoV-2 Omicron subvariant BA.2. N Engl J Med. 2022;386:1475–1477. - PMC - PubMed